Prognostic value of EGFR and p-EGFR in nasopharyngeal carcinoma: A systematic review and meta-analysis.

Hong, Xiaohua; Wang, Guangyao; Xu, Guanglan; Shi, Wei; Wang, Tongbiao; Rong, Zhen; Mo, Chunmei

Hong, Xiaohua; Wang, Guangyao; Xu, Guanglan; Shi, Wei; Wang, Tongbiao; Rong, Zhen; Mo, Chunmei.

Afiliação

Hong X; Guangxi University of Chinese medicine, NanNing Guangxi, China.
Wang G; The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning Guangxi, China.
Xu G; The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning Guangxi, China.
Shi W; The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning Guangxi, China.
Wang T; The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning Guangxi, China.
Rong Z; Bao'an Authentic TCM Therapy Hospital, Shenzhen Guangdong, China.
Mo C; Bao'an Authentic TCM Therapy Hospital, Shenzhen Guangdong, China.

Medicine (Baltimore) ; 101(3): e28507, 2022 Jan 21.

Article em En | MEDLINE | ID: mdl-35060503

Assuntos

Receptores ErbB/metabolismo; Carcinoma Nasofaríngeo/metabolismo; Neoplasias Nasofaríngeas/metabolismo; Receptores ErbB/genética; Humanos; Carcinoma Nasofaríngeo/mortalidade; Carcinoma Nasofaríngeo/patologia; Neoplasias Nasofaríngeas/mortalidade; Neoplasias Nasofaríngeas/patologia; Prognóstico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Nasofaríngeas / Receptores ErbB / Carcinoma Nasofaríngeo Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google